Identify evidence gaps early
JCA can span multiple populations, comparators, outcomes and national standards of care. A joined-up, cross-functional strategy is essential to identify evidence gaps early. https://ow.ly/nQop50ZYmqQ
#HTA #JCA #EvidenceGeneration
JCA can span multiple populations, comparators, outcomes and national standards of care. A joined-up, cross-functional strategy is essential to identify evidence gaps early. https://ow.ly/nQop50ZYmqQ
#HTA #JCA #EvidenceGeneration
October 29, 2026 at 11:00 AM
Identify evidence gaps early
JCA can span multiple populations, comparators, outcomes and national standards of care. A joined-up, cross-functional strategy is essential to identify evidence gaps early. https://ow.ly/nQop50ZYmqQ
#HTA #JCA #EvidenceGeneration
JCA can span multiple populations, comparators, outcomes and national standards of care. A joined-up, cross-functional strategy is essential to identify evidence gaps early. https://ow.ly/nQop50ZYmqQ
#HTA #JCA #EvidenceGeneration
Clinical outcomes. Patient perspectives. Regulatory insights. AI-enabled research.
These are just some of the topics ICON and Mapi Research Trust will be presenting at #ISPOREurope2026.
Visit booth #1615.
https://ow.ly/Wlmm50ZUkOQ
#ISPOR #EvidenceGeneration
These are just some of the topics ICON and Mapi Research Trust will be presenting at #ISPOREurope2026.
Visit booth #1615.
https://ow.ly/Wlmm50ZUkOQ
#ISPOR #EvidenceGeneration
October 28, 2026 at 11:00 AM
Clinical outcomes. Patient perspectives. Regulatory insights. AI-enabled research.
These are just some of the topics ICON and Mapi Research Trust will be presenting at #ISPOREurope2026.
Visit booth #1615.
https://ow.ly/Wlmm50ZUkOQ
#ISPOR #EvidenceGeneration
These are just some of the topics ICON and Mapi Research Trust will be presenting at #ISPOREurope2026.
Visit booth #1615.
https://ow.ly/Wlmm50ZUkOQ
#ISPOR #EvidenceGeneration
We're looking forward to sharing new research at #ISPOREurope2026 covering outcomes assessment, regulatory science, systematic reviews, quality-of-life research and AI-enabled methodologies.
Visit ICON at booth #1615.
https://ow.ly/1WOx50ZUkNg
#ISPOR #HEOR #EvidenceGeneration
Visit ICON at booth #1615.
https://ow.ly/1WOx50ZUkNg
#ISPOR #HEOR #EvidenceGeneration
October 14, 2026 at 4:00 PM
We're looking forward to sharing new research at #ISPOREurope2026 covering outcomes assessment, regulatory science, systematic reviews, quality-of-life research and AI-enabled methodologies.
Visit ICON at booth #1615.
https://ow.ly/1WOx50ZUkNg
#ISPOR #HEOR #EvidenceGeneration
Visit ICON at booth #1615.
https://ow.ly/1WOx50ZUkNg
#ISPOR #HEOR #EvidenceGeneration
🩺Digital health technologies have considerable potential to strengthen health systems, but unlocking this potential requires evidence to support informed decisions. 🔓
🔗 Read more: thesapphire.health/project/who-...
#DigitalHealth #DigitalHealthTechnologies #EvidenceGeneration #HTA #HITAP
🔗 Read more: thesapphire.health/project/who-...
#DigitalHealth #DigitalHealthTechnologies #EvidenceGeneration #HTA #HITAP
October 12, 2026 at 7:23 AM
🩺Digital health technologies have considerable potential to strengthen health systems, but unlocking this potential requires evidence to support informed decisions. 🔓
🔗 Read more: thesapphire.health/project/who-...
#DigitalHealth #DigitalHealthTechnologies #EvidenceGeneration #HTA #HITAP
🔗 Read more: thesapphire.health/project/who-...
#DigitalHealth #DigitalHealthTechnologies #EvidenceGeneration #HTA #HITAP
On 31 Aug, the @who.int convened 153 participants from industry, academia & regulatory bodies to discuss the challenges of #antibioticdevelopment and solutions.
Ecraid was contribute to the dialogue, and will help develop analyses to support future WHO guidance on #evidencegeneration.
Ecraid was contribute to the dialogue, and will help develop analyses to support future WHO guidance on #evidencegeneration.
September 4, 2026 at 12:04 PM
On 31 Aug, the @who.int convened 153 participants from industry, academia & regulatory bodies to discuss the challenges of #antibioticdevelopment and solutions.
Ecraid was contribute to the dialogue, and will help develop analyses to support future WHO guidance on #evidencegeneration.
Ecraid was contribute to the dialogue, and will help develop analyses to support future WHO guidance on #evidencegeneration.
From interoperability to regulatory compliance, EHDS is changing how real-world evidence studies are designed and delivered. Learn more: https://ow.ly/APfN50ZxmgL
#EuropeanHealthDataSpace #EvidenceGeneration #HealthcareInnovation
#EuropeanHealthDataSpace #EvidenceGeneration #HealthcareInnovation
September 2, 2026 at 9:00 AM
From interoperability to regulatory compliance, EHDS is changing how real-world evidence studies are designed and delivered. Learn more: https://ow.ly/APfN50ZxmgL
#EuropeanHealthDataSpace #EvidenceGeneration #HealthcareInnovation
#EuropeanHealthDataSpace #EvidenceGeneration #HealthcareInnovation
AI is rapidly changing the face of #EvidenceGeneration and #EvidenceSynthesis
REGISTER NOW for the next #EIS2027 free webinar 29 Sept
***AI for evidence: The perils and promise***
www.eisummit.org/events @cei-global.bsky.social
#HumanThinking #Research #Policy #Practice #AI
REGISTER NOW for the next #EIS2027 free webinar 29 Sept
***AI for evidence: The perils and promise***
www.eisummit.org/events @cei-global.bsky.social
#HumanThinking #Research #Policy #Practice #AI
August 17, 2026 at 2:01 AM
AI is rapidly changing the face of #EvidenceGeneration and #EvidenceSynthesis
REGISTER NOW for the next #EIS2027 free webinar 29 Sept
***AI for evidence: The perils and promise***
www.eisummit.org/events @cei-global.bsky.social
#HumanThinking #Research #Policy #Practice #AI
REGISTER NOW for the next #EIS2027 free webinar 29 Sept
***AI for evidence: The perils and promise***
www.eisummit.org/events @cei-global.bsky.social
#HumanThinking #Research #Policy #Practice #AI
Funding acknowledgement:
This work is made possible through catalytic support from the Gates Foundation—thank you for championing better, faster TB diagnostics. #Tuberculosis #Diagnostics #GlobalHealth #EvidenceGeneration #WHO #TBScience #Policy #Research
This work is made possible through catalytic support from the Gates Foundation—thank you for championing better, faster TB diagnostics. #Tuberculosis #Diagnostics #GlobalHealth #EvidenceGeneration #WHO #TBScience #Policy #Research
June 9, 2025 at 10:47 AM
Funding acknowledgement:
This work is made possible through catalytic support from the Gates Foundation—thank you for championing better, faster TB diagnostics. #Tuberculosis #Diagnostics #GlobalHealth #EvidenceGeneration #WHO #TBScience #Policy #Research
This work is made possible through catalytic support from the Gates Foundation—thank you for championing better, faster TB diagnostics. #Tuberculosis #Diagnostics #GlobalHealth #EvidenceGeneration #WHO #TBScience #Policy #Research
The use of AI in Evidence Generation
AI is reshaping evidence generation in Medical Affairs — not by replacing scientific judgment, but by making the process faster, more structured, and more actionable.
#MedicalAffairs #AI #EvidenceGeneration #RealWorldEvidence
AI is reshaping evidence generation in Medical Affairs — not by replacing scientific judgment, but by making the process faster, more structured, and more actionable.
#MedicalAffairs #AI #EvidenceGeneration #RealWorldEvidence
July 25, 2026 at 2:43 AM
The use of AI in Evidence Generation
AI is reshaping evidence generation in Medical Affairs — not by replacing scientific judgment, but by making the process faster, more structured, and more actionable.
#MedicalAffairs #AI #EvidenceGeneration #RealWorldEvidence
AI is reshaping evidence generation in Medical Affairs — not by replacing scientific judgment, but by making the process faster, more structured, and more actionable.
#MedicalAffairs #AI #EvidenceGeneration #RealWorldEvidence
Which metrics can highlight the scientific contribution of Medical Affairs i Business?
Watch the full session here: youtu.be/96B24YTzj1g
#ScientificLeadership #MedicalAffairs #MedicalStrategy #SkyHealthAcademy
Watch the full session here: youtu.be/96B24YTzj1g
#ScientificLeadership #MedicalAffairs #MedicalStrategy #SkyHealthAcademy
December 9, 2025 at 11:59 AM
Which metrics can highlight the scientific contribution of Medical Affairs i Business?
Watch the full session here: youtu.be/96B24YTzj1g
#ScientificLeadership #MedicalAffairs #MedicalStrategy #SkyHealthAcademy
Watch the full session here: youtu.be/96B24YTzj1g
#ScientificLeadership #MedicalAffairs #MedicalStrategy #SkyHealthAcademy
In this week’s tutorial we discuss 👉 how to use metrics to demonstrate evidence-based impact. Watch the full tutorial here ➡️ youtu.be/96B24YTzj1g
#MedicalAffairs #EvidenceGeneration #ScientificLeadership #SkyHealthAcademy
#MedicalAffairs #EvidenceGeneration #ScientificLeadership #SkyHealthAcademy
December 7, 2025 at 3:30 PM
In this week’s tutorial we discuss 👉 how to use metrics to demonstrate evidence-based impact. Watch the full tutorial here ➡️ youtu.be/96B24YTzj1g
#MedicalAffairs #EvidenceGeneration #ScientificLeadership #SkyHealthAcademy
#MedicalAffairs #EvidenceGeneration #ScientificLeadership #SkyHealthAcademy
In this week’s tutorial we discuss 👉 how to measure success in evidence generation activities.
Watch the full tutorial here ➡️ youtu.be/96B24YTzj1g
#EvidenceGeneration #MedicalAffairs #MedicalStrategy #SkyHealthAcademy
Watch the full tutorial here ➡️ youtu.be/96B24YTzj1g
#EvidenceGeneration #MedicalAffairs #MedicalStrategy #SkyHealthAcademy
December 6, 2025 at 9:19 AM
In this week’s tutorial we discuss 👉 how to measure success in evidence generation activities.
Watch the full tutorial here ➡️ youtu.be/96B24YTzj1g
#EvidenceGeneration #MedicalAffairs #MedicalStrategy #SkyHealthAcademy
Watch the full tutorial here ➡️ youtu.be/96B24YTzj1g
#EvidenceGeneration #MedicalAffairs #MedicalStrategy #SkyHealthAcademy
Faster evidence generation is possible with AI. Learn how: youtu.be/TVH3eeMsYIs
#MedicalAffairs #DigitalHealth #EvidenceGeneration #SkyHealthAcademy
#MedicalAffairs #DigitalHealth #EvidenceGeneration #SkyHealthAcademy
October 13, 2025 at 12:00 AM
Faster evidence generation is possible with AI. Learn how: youtu.be/TVH3eeMsYIs
#MedicalAffairs #DigitalHealth #EvidenceGeneration #SkyHealthAcademy
#MedicalAffairs #DigitalHealth #EvidenceGeneration #SkyHealthAcademy
AI is reshaping clinical research — here’s what Medical Affairs must know: youtu.be/TVH3eeMsYIs
#AIinMedicalAffairs #EvidenceGeneration #HealthcareInnovation #SkyHealthAcademy
#AIinMedicalAffairs #EvidenceGeneration #HealthcareInnovation #SkyHealthAcademy
October 12, 2025 at 3:00 AM
AI is reshaping clinical research — here’s what Medical Affairs must know: youtu.be/TVH3eeMsYIs
#AIinMedicalAffairs #EvidenceGeneration #HealthcareInnovation #SkyHealthAcademy
#AIinMedicalAffairs #EvidenceGeneration #HealthcareInnovation #SkyHealthAcademy
Better questions lead to better evidence generation. Find out why: youtu.be/dFuj5PaxhWg
#MedicalScienceLiaison #MSL #EvidenceGeneration #SkyHealthAcademy
#MedicalScienceLiaison #MSL #EvidenceGeneration #SkyHealthAcademy
October 10, 2025 at 12:00 AM
Better questions lead to better evidence generation. Find out why: youtu.be/dFuj5PaxhWg
#MedicalScienceLiaison #MSL #EvidenceGeneration #SkyHealthAcademy
#MedicalScienceLiaison #MSL #EvidenceGeneration #SkyHealthAcademy
#datastrategy #PharmaInsights #HealthcareInsights #FrontiersHealth2025 #MarketAccess #datastrategy #launchstrategy #Emergingdatasources #imaging #wearables #fitforpurposedata #AI #GenerativeAI #siloeddecisionmaking #datastrategy #evidencegeneration #commercialisation
zurl.co/JwOEj
zurl.co/JwOEj
Consolidating data strategy for global success: Insights from Frontiers Health 2025
At Frontiers Health 2025, Drew McCormick, Head of Data and Analytics at EVERSANA, emphasised a critical truth: data strategy is launch strategy.
zurl.co
December 18, 2025 at 10:38 AM
#Lumanity #PICI #pharmastrategy #pharmainsights #pharmalconsultancy #translationalresearch #marketresearch #clinicaldevelopment #evidencegeneration #marketaccessplanning #strategicdecisionmaking #regulatorypathways #accesspathways #reimbursementpathways
pharmatimes.com/news/lumanit...
pharmatimes.com/news/lumanit...
Lumanity and Parker Institute partner to support delivery of new immunotherapies - PharmaTimes
The alliance combines Lumanity’s commercial and development strategy capabilities with PICI’s translational research expertise
pharmatimes.com
May 30, 2025 at 2:03 PM
Rare disease teams often need robust evidence beyond what traditional trials can deliver—yet real-world data can be fragmented, hard to interpret, and risky to apply without the right approach. Check out our playbook guide: buff.ly/rlCw0JL
#RWE #RWD #RareDisease #EvidenceGeneration
#RWE #RWD #RareDisease #EvidenceGeneration
May 27, 2026 at 3:01 PM
Rare disease teams often need robust evidence beyond what traditional trials can deliver—yet real-world data can be fragmented, hard to interpret, and risky to apply without the right approach. Check out our playbook guide: buff.ly/rlCw0JL
#RWE #RWD #RareDisease #EvidenceGeneration
#RWE #RWD #RareDisease #EvidenceGeneration
Lumanity's #EvidenceNavigator™ is our comprehensive approach to Integrated Evidence Generation Planning (#IEGP), ensuring robust support for your asset’s #valuestory.
Read our latest paper at buff.ly/JSo1Ngw
#EvidencePlanning #EvidenceGeneration #MarketJourney
Read our latest paper at buff.ly/JSo1Ngw
#EvidencePlanning #EvidenceGeneration #MarketJourney
August 7, 2025 at 4:11 PM
Lumanity's #EvidenceNavigator™ is our comprehensive approach to Integrated Evidence Generation Planning (#IEGP), ensuring robust support for your asset’s #valuestory.
Read our latest paper at buff.ly/JSo1Ngw
#EvidencePlanning #EvidenceGeneration #MarketJourney
Read our latest paper at buff.ly/JSo1Ngw
#EvidencePlanning #EvidenceGeneration #MarketJourney
We’re excited to participate in the upcoming #MAPSEMEA2025 conference. Be sure to catch our presentation and connect with our staff at booth 35! Email contact@lumanity.com to schedule time to meet!
#MAPS #MAPSEMEA #MedicalAffairs #MedComms #Omnichannel #MSL #RWD #RWE #EvidenceGeneration
#MAPS #MAPSEMEA #MedicalAffairs #MedComms #Omnichannel #MSL #RWD #RWE #EvidenceGeneration
April 22, 2025 at 3:15 PM
We’re excited to participate in the upcoming #MAPSEMEA2025 conference. Be sure to catch our presentation and connect with our staff at booth 35! Email contact@lumanity.com to schedule time to meet!
#MAPS #MAPSEMEA #MedicalAffairs #MedComms #Omnichannel #MSL #RWD #RWE #EvidenceGeneration
#MAPS #MAPSEMEA #MedicalAffairs #MedComms #Omnichannel #MSL #RWD #RWE #EvidenceGeneration
JMIR Formative Res: Public Understanding and Expectations of Digital Health Evidence Generation: Focus Group Study #DigitalHealth #HealthApps #EvidenceGeneration #PublicHealth #HealthTech
Public Understanding and Expectations of Digital Health Evidence Generation: Focus Group Study
Background: The rapid proliferation of health apps has not been matched by a comparable growth in scientific evaluations of their effectiveness, particularly for apps available to the public. This gap has prompted ongoing debate about the types of…
dlvr.it
January 20, 2025 at 4:06 PM
JMIR Formative Res: Public Understanding and Expectations of Digital Health Evidence Generation: Focus Group Study #DigitalHealth #HealthApps #EvidenceGeneration #PublicHealth #HealthTech
New in JHEOR: A multi-country, stakeholder-informed framework that considers the value drivers of PSM technologies, mapping these to payer and HTA evaluation criteria to guide evidence generation and reimbursement decision making. jheor.org/article/163078 #HEOR #EvidenceGeneration #HTA #evaluation
June 16, 2026 at 6:57 PM
New in JHEOR: A multi-country, stakeholder-informed framework that considers the value drivers of PSM technologies, mapping these to payer and HTA evaluation criteria to guide evidence generation and reimbursement decision making. jheor.org/article/163078 #HEOR #EvidenceGeneration #HTA #evaluation
🔬 Digital health technologies offer real-time data linking and cross-therapy evidence generation. Stakeholder engagement is crucial for meaningful insights! #HealthTech #EvidenceGeneration
June 17, 2025 at 3:32 PM
🔬 Digital health technologies offer real-time data linking and cross-therapy evidence generation. Stakeholder engagement is crucial for meaningful insights! #HealthTech #EvidenceGeneration
Label expansion rarely follows a clean, linear path, however, #RWE can support this early “radar” function by identifying emerging use patterns, characterizing where and in whom they occur, and prioritizing signals of #effectiveness. Read on: lumanity.com/perspectives...
#EvidenceGeneration
#EvidenceGeneration
June 1, 2026 at 10:45 AM
Label expansion rarely follows a clean, linear path, however, #RWE can support this early “radar” function by identifying emerging use patterns, characterizing where and in whom they occur, and prioritizing signals of #effectiveness. Read on: lumanity.com/perspectives...
#EvidenceGeneration
#EvidenceGeneration
Rare disease teams often need robust evidence beyond what traditional trials can deliver—yet real-world data can be fragmented, hard to interpret, and risky to apply without the right approach. Check out our playbook guide: lumanity.com/perspectives...
#RWE #RWD #RareDisease #EvidenceGeneration
#RWE #RWD #RareDisease #EvidenceGeneration
May 27, 2026 at 9:30 AM
Rare disease teams often need robust evidence beyond what traditional trials can deliver—yet real-world data can be fragmented, hard to interpret, and risky to apply without the right approach. Check out our playbook guide: lumanity.com/perspectives...
#RWE #RWD #RareDisease #EvidenceGeneration
#RWE #RWD #RareDisease #EvidenceGeneration